OTC Monograph Reform: Deemed Final Orders Published 2022-01-04 Download video MP4 360p Download video MP4 720p Recommendations 42:44 OTC Monograph Reform: OTC Sunscreen Drugs 55:40 Nonprescription Drug Product with an Additional Condition for Nonprescription Use 53:25 OTC Monograph Reform: OMOR Format and Content & Electronic Submissions 51:01 OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2023 User Fees and Registration 1:24:08 Electronic Drug Registration and Listing (eDRLS) Using CDER Direct Part 1 with Keynote Address 54:40 OTC Monograph Reform Overview of Draft Guidance for Formal Meetings 49:43 OTC Monograph Reform in the CARES Act: Safety Orders 56:47 Monograph reform is here! Learn what to expect and how to prepare. 1:30:38 Conversations on Cancer: Transforming Patient Lives by Therapeutic and Regulatory Innovations 7:06:50 FDA-MHRA-HC 2024 Joint Symposium (Day 1) 8:28:56 FDA-MHRA-HC 2024 Joint Symposium (Day 3) 05:55 10 datos sobre lo que la FDA aprueba y no aprueba #DatosDeLaFDA 06:14 A Day in the Life of an Import Investigator 06:05 Episode 3 - On The Road with Jim Jones - Jan 2024 7:44:58 FDA-MHRA-HC 2024 Joint Symposium (Day 2) 04:50 A Conversation With Janet Woodcock, M.D. and Namandjé Bumpus, Ph.D. 00:26 ¿Sabes que los medicamentos de fórmulas magistrales no están aprobados por la FDA? #DatosDeLaFDA 19:43 Bridging Gaps in Health Equity: A Conversation with Dr. Claudia Baquet 05:19 Episode 2 - On The Road with Jim Jones - Nov 2023 8:22:00 September 11-12, 2023 Meeting of the Nonprescription Drugs Advisory Committee (NDAC) - Day 1 Similar videos 35:18 OTC Monograph Regulations Part 1 of 5 49:29 OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2021 User Fees 04:07 What is the Over-the-Counter (OTC) Drug Monograph Process? 35:16 Overview of Postmarketing Drug Safety Reporting Requirements - REdI 2020 2:48:30 Modernizing FDA’s Regulationof Over-the-Counter Drugs 22:17 CDER NextGen Portal 24:59 Drug Substance Facilities – Hidden and Critical Intermediate 8:57:11 Drug Development Considerations for the Prevention of HAIs 14:52 Postmarketing Safety and Surveillance of Generic Drugs Update 57:37 Risk Evaluation and Mitigation Strategies (REMS) Compliance Program 7:49:25 September 13, 2023 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC) 00:39 RX-to-OTC Switch Symposium 1:06:01 MTF Medical Toxicology in Industry Webinar: Regulation of Over-the-Counter Products More results